Основные подходы тканевой инженерии

Краткий обзорно-лекционный материал посвящен одному из ключевых направлений регенеративной медицины тканевой инженерии с использованием стволовых и мультипотентных клеток. Среди рассматриваемых технологий: классическая тканевая инженерия с использованием скаффолдов, сфероидные подходы, клеточные пласты. В статье рассматриваются и освещены базовые принципы тканевой инженерии (триада компонентов, основные технологии) и ограничения, связанные с использованием данной группы подходов в клинической практике.

1. Ntege EH, Sunami H, Shimizu Y. Advances in regenerative therapy: A review of the literature and future directions. Regen Ther, 2020;14:136–153.

2. Raveh-Amit H, Berzsenyi S, Vas V, et al. Tissue resident stem cells: till death do us part. Biogerontology, 2013;14(6):573–590.

3. Макаревич П.И., Ефименко А.Ю., Ткачук В.А. Биохимическая регуляция регенеративных процессов факторами роста и цитокинами: основные механизмы и значимость для регенеративной медицины // Биохимия. — 2020. — Том 85, № 1. — С. 15–33.

4. Kolios G, Moodley Y. Introduction to stem cells and regenerative medicine. Respiration, 2013;85(1):3–10.

5. Vacanti CA, Vacanti JP. Functional organ replacement, the new technology of tissue engineering. Surg Technol Int, 1991;I:43–49.

6. Sharma B, Elisseeff JH. Engineering structurally organized cartilage and bone tissues. Ann Biomed Eng, 2004;32(1):148–159.

7. Chan BP, Leong KW. Scaffolding in tissue engineering: general approaches and tis-sue-specific considerations. Eur Spine J, 2008;17(4):467–479.

8. Barzegari A., Saei A.A. An update to space biomedical research: tissue engineering in microgravity bioreactors. Bioimpacts, 2012;2(1):23–32.

9. Berthiaume F, Maguire TJ, Yarmush ML. Tissue engineering and regenerative medicine: history, progress, and challenges. Annu Rev Chem Biomol Eng, 2011;2:403–430.

10. Lim D, Renteria ES, Sime DS, et al. Bioreactor design and validation for manufacturing strategies in tissue engineering. Biodes Manuf, 2022;5(1):43–63.

11. Abdelaziz AG, Nageh H, Abdo SM, et al. A review of 3D polymeric scaffolds for bone tissue engineering: principles, fabrication techniques, immunomodulatory roles, and challenges. Bioengineering, 2023;10(2):204.

12. Kim Y, Ko H, Kwon IK, et al. Extracellular matrix revisited: roles in tissue engineering. Int Neurourol J, 2016;20(1):S23–29.

13. Басок Ю.Б., Севастьянов В.И. Технологии тканевой инженерии и регенеративной медицины в лечении дефектов хрящевой ткани суставов // Вестник трансплантологии и искусственных органов. — 2016. — Том 18, № 4. — С. 102–122.

14. Бекетов Е.Е., Исаева Е.В., Шегай П.В. и др. Современное состояние тканевой инженерии для восстановления хрящевой ткани. // Гены и Клетки, 2019. — Том 14, № 2. — С. 12–20.

15. Yang D, Xiao J., Wang B., et al. The immune reaction and degradation fate of scaffold in cartilage/bone tissue engineering. Mater Sci Eng C Mater Biol Appl, 2019;104:109927.

16. Baier Leach J., Bivens KA, Patrick CW, Jr., et al. Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng, 2003;82(5):578–589.

17. Chevallay B., Herbage D. Collagen-based biomaterials as 3D scaffold for cell cultures: applications for tissue engineering and gene therapy. Med Biol Eng Comput, 2000;38(2):211–218.

18. Chevalier E, Chulia D, Pouget C, et al. Fabrication of porous substrates: a review of processes using pore forming agents in the biomaterial field. J Pharm Sci, 2008;97(3):1135–1154.

19. Dhariwala B., Hunt E, Boland T. Rapid prototyping of tissue-engineering constructs, using photopolymerizable hydrogels and stereolithography. Tissue Eng, 2004;10(9–10):1316–1322.

20. Meinel L, Karageorgiou V, Fajardo R, et al. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Annals of biomedical engineering, 2004;32:112–122.

21. Cui X, Hartanto Y, Zhang H. Advances in multicellular spheroids formation. J R Soc Interface, 2017;14(127):20160877.

22. Gilbert TW, Sellaro TL, Badylak SF. Decellularization of tissues and organs. Biomaterials,2006;27(19):3675–3683.

23. Hall S. Axonal regeneration through acellular muscle grafts. J Anat, 1997;190(Pt1):57–71.

24. Ingram JH, Korossis S, Howling G, et al. The use of ultrasonication to aid recellularization of acellular natural tissue scaffolds for use in anterior cruciate ligament reconstruction. Tissue Eng, 2007;13(7):1561–1572.

25. Исаева Е.В., Бекетов Е.Е., Аргучинская Н.В. и др. Децеллюляризованный внеклеточный матрикс для тканевой инженерии (обзор) // Современные технологии в медицине — 2022. — Том 14, № 3. — С. 57–69.

26. Safdari M., Bibak B, Soltani H, et al. Recent advancements in decellularized matrix technology for bone tissue engineering. Differentiation, 2021;121:25–34.

27. Ott HC, Matthiesen TS, Goh S-K, et al. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart. Nature Medicine, 2008;14(2):213–221.

28. Barakat O, Abbasi S, Rodriguez G, et al. Use of decellularized porcine liver for engineering humanized liver organ. J Surg Res, 2012;173(1):e11–25.

29. Мелконян К.И., Бирюкова А.О., Улитина Н.Н. и др. Компоненты внеклеточного матрикса в восстановлении поврежденных тканей: биохимические взаимодействия и протективный эффект // Крымский журнал экспериментальной и клинической медицины. — 2019. — Том 9, № 4. — С. 55–62.

30. Porzionato A, Stocco E, Barbon S, et al. Tissue-engineered grafts from human decellularized extracellular matrices: a systematic review and future perspectives. Int J Mol Sci, 2018;19(12):4117.

31. Kelm JM, Timmins NE, Brown CJ, et al. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng, 2003;83(2):173–180.

32. Foty R. A simple hanging drop cell culture protocol for generation of 3D spheroids. J Vis Exp,2011;51:2720.

33. Lin RZ, Chang HY. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J, 2008;3(9-10):1172–1184.

34. Habanjar O., Diab-Assaf M, Caldefie-Chezet F, et al. 3D cell culture systems: tumor application, advantages, and disadvantages. Int J Mol Sci, 2021;22(22):12200.

35. LaBarbera DV, Reid BG, Yoo BH. The multicellular tumor spheroid model for high-through-put cancer drug discovery. Expert Opin Drug Discov, 2012;7(9):819–830.

36. Грядунова А.А., Буланова Е.А., Кудан Е.В. и др. Масштабируемая биофабрикация и морфологическая оценка тканевых сфероидов // Клиническая и экспериментальная морфология. — 2019. — Том 8, № 2. — С. 12–20.

37. Mandrycky C, Wang Z, Kim K, et al. 3D bioprinting for engineering complex tissues. Biotechnol Adv, 2016;34(4):422–434.

38. Murphy SV, Atala A. 3D bioprinting of tissues and organs. Nat Biotechnol, 2014;32(8): 773–785.

39. Хесуани Ю.Д., Сергеева Н.С., Миронов В.А. и др. Введение в 3D-биопринтинг: история формирования направления, принципы и этапы биопечати // Гены и Клетки. — 2018. — Том 13, № 3. — С. 38–45.

40. Derakhshanfar S, Mbeleck R, Xu K, et al. 3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances. Bioact Mater, 2018;3(2):144–156.

41. Bertassoni LE, Cecconi M, Manoharan V, et al. Hydrogel bioprinted microchannel networks for vascularization of tissue engineering constructs. Lab Chip, 2014;14(13):2202–2211.

42. Kolesky DB, Truby RL, Gladman AS, et al. 3D bioprinting of vascularized, heterogeneous cell-laden tissue constructs. Adv Mater, 2014;26(19):3124–3130.

43. Duan B, Kapetanovic E, Hockaday LA, et al. Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells. Acta Biomater, 2014;10(5):1836–1846.

44. Li J, Chen M, Fan X, et al. Recent advances in bioprinting techniques: approaches, applications and future prospects. J Transl Med, 2016;14:271.

45. Castilho M, Moseke C., Ewald A., et al. Direct 3D powder printing of biphasic calcium phosphate scaffolds for substitution of complex bone defects. Biofabrication, 2014;6(1):015006.

46. Pati F, Song TH, Rijal G, et al. Ornamenting 3D printed scaffolds with cell-laid extracellular matrix for bone tissue regeneration. Biomaterials, 2015;37:230–241.

47. Lee JS, Hong JM, Jung JW, et al. 3D printing of composite tissue with complex shape applied to ear regeneration. Biofabrication, 2014;6(2):024103.

48. Antich C, de Vicente J, Jimenez G, et al. Bioinspired hydrogel composed of hyaluronic acid and alginate as a potential bioink for 3D bioprinting of articular cartilage engineering constructs. Acta Biomater, 2020;106:114–123.

49. Li C, Wang K, Zhou X, et al. Controllable fabrication of hydroxybutyl chitosan/oxidized chondroitin sulfate hydrogels by 3D bioprinting technique for cartilage tissue engineering. Biomed Mater, 2019;14(2):025006.

50. Aleksandrushkina NA., Danilova NV, Grigorieva OA, et al. Cell sheets of mesenchymal stromal cells effectively stimulate healing of deep soft tissue defects. Bull Exp Biol Med, 2019;167(1):159–163.

51. Yamato M, Okano T. Cell sheet engineering. Materials Today, 2004;7(5):42–47.

52. Kanai N, Yamato M, Okano T. Cell sheets engineering for esophageal regenerative medicine. Ann Transl Med, 2014;2(3):28.

53. Chen M, Xu Y, Zhang T, et al. Mesenchymal stem cell sheets: a new cell-based strategy for bone repair and regeneration. Biotechnol Lett, 2019;41(3):305–318.

54. Tsumanuma Y, Iwata T, Washio K, et al. Comparison of different tissue-derived stem cell sheets for periodontal regeneration in a canine 1-wall defect model. Biomaterials, 2011;32(25):5819–5825.

55. Chang D, Fan T, Gao S, et al. Application of mesenchymal stem cell sheet to treatment of ischemic heart disease. Stem Cell Res Ther, 2021;12(1):384.

56. Allan D, Tieu A, Lalu M, et al. Mesenchymal stromal cell-derived extracellular vesicles for regenerative therapy and immune modulation: Progress and challenges toward clinical application. Stem Cells Transl Med, 2020;9(1):39–46.

57. Дергилёв К.В., Цоколаева З.И., Белоглазова И.Б. и др. Сравнительная эффективность эпикардиальной трансплантации прогениторных клеток сердца в виде клеточных пластов и интрамиокардиальных инъекций при стимуляции регенеративных процессов в постинфарктном сердце // Кардиология. — 2019. — Том 59, № 5. p. 53–60.

58. Nishida K, Yamato M, Hayashida Y, et al. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. New England Journal of Medicine, 2004;351(12):1187–1196.

59. Ohki T, Yamato M, Ota M, et al. Prevention of esophageal stricture after endoscopic sub-mucosal dissection using tissue-engineered cell sheets. Gastroenterology, 2012;143(3):582–588.

60. Alexandrushkina N, Nimiritsky P, Eremichev R, et al. Cell sheets from adipose tissue MSC induce healing of pressure ulcer and prevent fibrosis via trigger effects on granulation tis-sue growth and vascularization. Int J Mol Sci, 2020;21(15):5567.

61. Matsuda N, Shimizu T, Yamato M, et al. Tissue engineering based on cell sheet technology. Advanced Materials, 2007;19(20):3089–3099.

62. Shimizu T, Yamato M, Kikuchi A, et al. Two-dimensional manipulation of cardiac myocyte sheets utilizing temperature-responsive culture dishes augments the pulsatile amplitude. Tissue engineering, 2001;7(2):141–151.

63. Matsuura K, Masuda S, Shimizu T. Cell sheet-based cardiac tissue engineering. The Anatomical Record, 2014; 297(1):65–72.

64. Sekine H, Shimizu T., Okano T. Myocardial tissue engineering: toward a bioartificial pump. Cell and Tissue Research, 2012;347(3):775–782.

65. Song SY, Kim H, Yoo J, et al. Prevascularized, multiple-layered cell sheets of direct cardiac reprogrammed cells for cardiac repair. Biomaterials science, 2020;8(16):4508–4520.

66. Syverud BC, VanDusen KW, Larkin LM. Growth factors for skeletal muscle tissue engineering. Cells Tissues Organs, 2016;202(3-4):169–179.

67. Walker MR, Patel KK, Stappenbeck TS. The stem cell niche. J Pathol, 2009;217(2):169–180.

68. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol, 1994;124(4):619–626.

69. Mamidi MK, Singh G, Husin JM, et al. Impact of passing mesenchymal stem cells through smaller bore size needles for subsequent use in patients for clinical or cosmetic indications. J Transl Med, 2012;10:229.

70. Rangatchew F., Rasmussen BS, Svalgaard JD, et al. Efficacy of mesenchymal stem cell-de-livery using perpendicular multi-needle injections to the skin: Evaluation of post-ejection cellular health and dermal delivery. Burns, 2023;49(3):633–645.

71. Lalu, MM, McIntyre L, Pugliese C, et al. Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials. PLoS One, 2012;7(10):e47559.

72. Trounson A, McDonald C. Stem cell therapies in clinical trials: progress and challenges. Cell Stem Cell, 2015;17(1):11–22.

73. Meinel L, Fajardo R, Hofmann S, et al. Silk implants for the healing of critical size bone defects. Bone, 2005;37(5):688–698.

74. Roddy E, DeBaun MR, Daoud-Gray A, et al. Treatment of critical-sized bone defects: clinical and tissue engineering perspectives. Eur J Orthop Surg Traumatol, 2018;28(3):351–362.

75. Matsuzaki Y, John K, Shoji T, et al. The Evolution of Tissue Engineered Vascular Graft Technologies: From Preclinical Trials to Advancing Patient Care. Appl Sci, 2019;9(7).

76. Shin’oka, T, Imai Y, Ikada Y. Transplantation of a tissue-engineered pulmonary artery. N Engl J Med, 2001;344(7):532–533.

77. Boyce ST, Kagan RJ, Yakuboff KP, et al. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg, 2002;235(2):269–279.